Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/16/2025

Gabapentin Interactions with CNS Medications

Introduction to Gabapentin Interactions

  • The American Geriatrics Society warns against the combination of gabapentin with opioids, benzodiazepines, or other CNS depressants due to a significant increase in the risk of respiratory depression, sedation, and death, and this combination should be avoided whenever possible 1, 2

Key Interactions with CNS Medications

  • The combination of gabapentin and benzodiazepines significantly increases the risk of respiratory depression and sedation, particularly in elderly patients who are more sensitive to CNS depressant effects 1, 2
  • The American Geriatrics Society specifically warns against the combination of gabapentin and benzodiazepines in their Beers Criteria 1, 2
  • Gabapentin combined with serotonin-norepinephrine reuptake inhibitors (SNRIs) increases fall risk, particularly in older adults 2
  • Tricyclic antidepressants (TCAs) with gabapentin can cause additive sedation and anticholinergic effects 2
  • SSRIs combined with gabapentin may increase CNS depression, though to a lesser extent than with SNRIs 1

Risk Factors for Severe Interactions

  • Advanced age (>65 years) is a risk factor for severe interactions 1, 4
  • Pre-existing respiratory conditions, including obstructive sleep apnea, increase the risk of severe interactions 5
  • Concurrent use of multiple CNS depressants increases the risk of severe interactions 2

Special Populations

  • In elderly patients, the risk of adverse effects from CNS medication combinations is substantially higher 1, 2

Clinical Recommendations

  • Avoid concurrent use of gabapentin with opioids, benzodiazepines, and other CNS depressants whenever possible 1, 2
  • Consider non-CNS depressant alternatives for pain management when appropriate 4
  • Regularly reassess the need for continued therapy with multiple CNS-active medications 1